Previous 10 | Next 10 |
Koss (KOSS) -14%.C3.ai (AI) -11% on FQ4 earnings release.Stealth BioTherapeutics (MITO) -11%.Express (EXPR) -11% on Q1 earnings releaseFireEye (FEYE) -10% after spins out FireEye Products business to Symphony for $1.2B.Bed Bath & Beyond (BBBY) -10%.PetMed Exp...
Syneos Health (SYNH) announces that it has commenced an underwritten secondary offering of an aggregate of 10.85M shares.The company highlighted that it is not selling any shares and will not receive any proceeds from the offering.Shares down more than 4% post market. For further detai...
Syneos Health saw its share price increase by about 25% since my previous article, and I missed the boat as my limit order didn't get hit. Despite the strong recent performance, Syneos still isn't expensive as it's performing slightly ahead of expectations. The secondary offering ...
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior Director, Clinical Operations and Clinical Development Services, and Katya Magonova, MBA...
Syneos Health (SYNH) has commenced an underwritten secondary offering of 7M shares.Selling stockholders intend to grant the underwriter a 30-day option to purchase up to 1.05M additional shares.Syneos Health is not selling any shares and will not receive any proceeds from the sale. For furt...
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship with Komodo Health, a data-driven healthcare software company with access to the b...
Syneos Health, Inc. (SYNH) Q1 2021 Earnings Conference Call April 29, 2021, 08:00 ET Company Participants Ronnie Speight - SVP, IR Alistair Macdonald - CEO & Director Jason Meggs - CFO Paul Colvin - President, Clinical Solutions Michelle Keefe - President, Commercial Solutions Conference ...
Image source: The Motley Fool. Syneos Health, Inc. (NASDAQ: SYNH) Q1 2021 Earnings Call Apr 30, 2021 , 12:00 p.m. ET Ronnie Speight -- Senior Vice President, Investor Relations Continue reading For further details see: Syneos Health, ...
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health ® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade. Illingworth Research Group™ is a leading global provider of clinical ...
Syneos Health (SYNH): Q1 Non-GAAP EPS of $0.79 beats by $0.05; GAAP EPS of $0.37 beats by $0.13.Revenue of $1.21B (+4.3% Y/Y) beats by $20M.Press Release For further details see: Syneos Health EPS beats by $0.05, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...